• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta grows to more than 15% of U.S. patient care with new members, closing series A funding with nearly $100 million

Truveta grows to more than 15% of U.S. patient care with new members, closing series A funding with nearly $100 million

by Terry Myerson, CEO | Jul 13, 2021 | News

I will never forget when I first wrote the words Hello from Truveta. I was the first employee of a new startup imagined by several innovative healthcare leaders who believed that by working together we could achieve a compelling vision: Saving Lives with Data. What...

Share this


Recent posts

  • How Truveta benchmarks AI model quality for clinical concept extraction
  • Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures
  • Evaluating recent trends in early measles vaccinations in Texas

Follow Truveta


Sign up for our newsletter

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice